BBIO
Price
$44.85
Change
-$0.27 (-0.60%)
Updated
Jun 27 closing price
Capitalization
8.52B
31 days until earnings call
ROIV
Price
$11.39
Change
-$0.21 (-1.81%)
Updated
Jun 27 closing price
Capitalization
7.74B
49 days until earnings call
Interact to see
Advertisement

BBIO vs ROIV

Header iconBBIO vs ROIV Comparison
Open Charts BBIO vs ROIVBanner chart's image
BridgeBio Pharma
Price$44.85
Change-$0.27 (-0.60%)
Volume$8.45M
Capitalization8.52B
Roivant Sciences
Price$11.39
Change-$0.21 (-1.81%)
Volume$11.13M
Capitalization7.74B
BBIO vs ROIV Comparison Chart in %
Loading...
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BBIO vs. ROIV commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBIO is a Buy and ROIV is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (BBIO: $44.85 vs. ROIV: $11.39)
Brand notoriety: BBIO and ROIV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BBIO: 263% vs. ROIV: 182%
Market capitalization -- BBIO: $8.52B vs. ROIV: $7.74B
BBIO [@Biotechnology] is valued at $8.52B. ROIV’s [@Biotechnology] market capitalization is $7.74B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BBIO’s FA Score shows that 1 FA rating(s) are green whileROIV’s FA Score has 0 green FA rating(s).

  • BBIO’s FA Score: 1 green, 4 red.
  • ROIV’s FA Score: 0 green, 5 red.
According to our system of comparison, BBIO is a better buy in the long-term than ROIV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BBIO’s TA Score shows that 6 TA indicator(s) are bullish while ROIV’s TA Score has 3 bullish TA indicator(s).

  • BBIO’s TA Score: 6 bullish, 4 bearish.
  • ROIV’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, BBIO is a better buy in the short-term than ROIV.

Price Growth

BBIO (@Biotechnology) experienced а +7.49% price change this week, while ROIV (@Biotechnology) price change was -0.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

BBIO is expected to report earnings on Jul 31, 2025.

ROIV is expected to report earnings on Aug 18, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BBIO($8.52B) has a higher market cap than ROIV($7.74B). BBIO YTD gains are higher at: 63.466 vs. ROIV (-3.719). BBIO has higher annual earnings (EBITDA): -551.92M vs. ROIV (-1.1B). ROIV has more cash in the bank: 4.89B vs. BBIO (541M). ROIV has less debt than BBIO: ROIV (100M) vs BBIO (1.86B). BBIO has higher revenues than ROIV: BBIO (127M) vs ROIV (29.1M).
BBIOROIVBBIO / ROIV
Capitalization8.52B7.74B110%
EBITDA-551.92M-1.1B50%
Gain YTD63.466-3.719-1,706%
P/E RatioN/A1.97-
Revenue127M29.1M436%
Total Cash541M4.89B11%
Total Debt1.86B100M1,858%
FUNDAMENTALS RATINGS
BBIO: Fundamental Ratings
BBIO
OUTLOOK RATING
1..100
36
VALUATION
overvalued / fair valued / undervalued
1..100
4
Undervalued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BBIOROIV
RSI
ODDS (%)
Bearish Trend 4 days ago
80%
N/A
Stochastic
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
73%
MACD
ODDS (%)
Bullish Trend 4 days ago
73%
Bullish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
77%
Bearish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 15 days ago
78%
Bullish Trend 11 days ago
71%
Declines
ODDS (%)
Bearish Trend 13 days ago
85%
Bearish Trend 15 days ago
73%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
62%
Aroon
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BBIO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ROIV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPYU42.400.65
+1.56%
MAX S&P 500 4X Leveraged ETN
ICOW34.060.13
+0.38%
Pacer Dev Mkts Intl Csh Cows 100 ETF
ASET32.500.12
+0.36%
FlexShares Real Assets Allocation ETF
PRAY30.580.09
+0.29%
FIS Christian Stock ETF
BILZ101.190.04
+0.04%
PIMCO Ultra Short Government Active ETF

BBIO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BBIO has been loosely correlated with ARGX. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if BBIO jumps, then ARGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BBIO
1D Price
Change %
BBIO100%
-0.59%
ARGX - BBIO
46%
Loosely correlated
+0.02%
XENE - BBIO
41%
Loosely correlated
+0.62%
ROIV - BBIO
41%
Loosely correlated
-1.81%
CGEN - BBIO
40%
Loosely correlated
-1.78%
PMN - BBIO
40%
Loosely correlated
-0.97%
More

ROIV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ROIV has been loosely correlated with IMVT. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if ROIV jumps, then IMVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ROIV
1D Price
Change %
ROIV100%
-1.81%
IMVT - ROIV
62%
Loosely correlated
-1.77%
ACLX - ROIV
52%
Loosely correlated
+0.90%
CRNX - ROIV
51%
Loosely correlated
-0.10%
KRYS - ROIV
51%
Loosely correlated
-2.60%
CGON - ROIV
50%
Loosely correlated
-0.46%
More